川宁生物

- 301301

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018 
川宁生物(301301) 利润表
单位:万元
报表日期2024-09-302024-06-302024-03-312023-12-312023-09-30
一、营业总收入445,626.56319,542.67152,321.82482,333.50358,133.34
营业收入445,626.56319,542.67152,321.82482,333.50358,133.34
二、营业总成本315,449.44226,406.29109,863.98364,883.00276,837.23
营业成本285,999.02206,705.3299,893.50330,039.71250,931.85
营业税金及附加6,749.734,643.351,971.816,664.605,414.42
销售费用1,957.021,159.56384.742,256.651,462.89
管理费用12,090.728,249.044,679.0114,313.1510,707.38
财务费用4,246.332,770.981,266.716,083.104,414.97
研发费用4,406.612,878.051,668.225,525.813,905.72
资产减值损失----------
公允价值变动收益64.45-22.46-51.99-118.40-181.84
投资收益-715.85-631.21-306.55-1,355.07-1,158.12
其中:对联营企业和合营企业的投资收益-36.54-10.56-3.89-14.55-10.58
汇兑收益----------
三、营业利润129,471.5591,968.0542,322.75112,139.9777,673.77
加:营业外收入107.276.744.54197.9919.08
减:营业外支出1,786.611,059.08135.33566.85833.90
其中:非流动资产处置损失----------
四、利润总额127,792.2190,915.7142,191.96111,771.1176,858.95
减:所得税费用20,196.5014,282.956,929.3517,714.6112,843.99
五、净利润107,595.7176,632.7635,262.6194,056.5064,014.96
归属于母公司所有者的净利润107,591.8576,630.4135,261.4994,056.4064,014.98
少数股东损益3.852.351.120.10-0.02
六、每股收益
基本每股收益(元/股)0.48000.34000.16000.42000.2900
稀释每股收益(元/股)0.48000.34000.16000.42000.2900
七、其他综合收益----------
八、综合收益总额107,595.7176,632.7635,262.6194,056.5064,014.96
归属于母公司所有者的综合收益总额107,591.8576,630.4135,261.4994,056.4064,014.98
归属于少数股东的综合收益总额3.852.351.120.10-0.02
下载全部历史数据到excel中 返回页顶